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Targeted therapy towards tumor cells has been regarded
as a promising strategy, since it offers the possibility of
directing and concentrating the therapeutic agent only
at the desired target site, increasing therapeutic efficacy
through increased tumor cell death and decreased inci-
dence of side effects in healthy tissues. Nonetheless,
choosing only one cellular target within the tumor
microenvironment is an approach with low probabilities
to succeed. In this respect, we aim at designing a non-
viral vector that targets, simultaneously, tumor cells and
endothelial cells from tumor blood vessels. It is
hypothesized that such nanoparticle, with this dual tar-
geting ability, will present an active tumor accumulation.
Specific intracellular release of the encapsulated payload
will strongly contribute to improve the therapeutic
outcome.
Our results show a substantial increase in the levels of
association for ligand-targeted nanoparticles, on a
ligand- and cell-specific manner, both in vitro and
ex vivo (in breast tumor cells removed from patients,
after mastectomy or tumorectomy). Cytotoxicity studies
show that targeted nanoparticles containing doxorubicin
are more cytotoxic than the non-targeted formulation (4
to 180-fold), against tumor and endothelial cells, indicat-
ing that internalization of the former is contributing to a
more efficient delivery of the payload to the target cells.
Experiments with tumor-bearing mice report a higher
tumor accumulation of the radiolabeled targeted nano-
particle over the non-targeted counterpart. Overall,
these results represent a novel and a valuable contribu-
tion for delivery strategies targeting tumor cells and the
tumor microenvironment.
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